Article

Precision Dopaminergic Treatment in a Cohort of Parkinson’s disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review

2024-05-09

Abstract excerpt

<h4>Introduction: </h4> Parkinson’s disease (PD) patients harboring recessive gene variants exhibit a distinct clinical phenotype with an early disease onset and relatively mild symptoms. Data concerning individualized therapy for autosomal recessive PD forms are still scarce. <h4>Methods:</h4> Demographic and treatment data of a cohort of PD carriers of recessive genes (9 homozygous or compound heterozygous PRKN...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: da7ac177-fa89-52e8-8bcd-4e2a59939586
DOI: 10.20944/preprints202405.0524.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Precision Dopaminergic Treatment in a Cohort of Parkinson’s disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini ReviewDOI 10.20944/preprints202405.0524.v1Read

Therapies for Genetic Forms of Parkinson's Disease: Systematic Literature Review.Semantic proximity Read

Parkinson’s Disease Pharmacogenomics: New Findings and PerspectivesSemantic proximity Read

Precision medicine for Parkinson’s disease: The subtyping challengeSemantic proximity Read

Autosomal recessive parkinsonism.Semantic proximity Read

[Genetics and present therapy options in Parkinson's disease: a review].Semantic proximity Read

Pharmacogenomics—a New Frontier for Individualized Treatment of Parkinson’s DiseaseSemantic proximity Read

Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic StudiesSemantic proximity Read

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism.Semantic proximity Read

Characterization of Recessive Parkinson Disease in a Large Multicenter Study.Semantic proximity Read

Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased riskSemantic proximity Read

Anti-Parkinson's disease drugs and pharmacogenetic considerationsSemantic proximity Read

[Hereditary Parkinson disease. The Danish Society of Movement Disorders].Semantic proximity Read